ITGAX and neoplasm: Multicolor immunohistochemical analysis showed a notable enrichment of MHC-II+CD11c+ cells, which are indicative of potential DCs, in tumor tissues exhibiting elevated levels of PD-L1 and PD-L2 (Figure 5).